Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Post-mastectomy Pain Syndrome|Breast Cancer|Pain, Postoperative|Pain, Chronic
Interventions: DRUG: Lidocaine 20mg/ml|DRUG: Placebo
Sponsor: University Health Network, Toronto
Collaborators: Canadian Institutes of Health Research (CIHR)